Taro Pharmaceutical Industries Ltd.
TARO · NYSE
3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $54 | $25 | $58 | -$401 |
| Dep. & Amort. | $31 | $32 | $26 | $24 |
| Deferred Tax | $19 | $17 | $23 | -$38 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $28 | -$38 | -$279 | $461 |
| Other Non-Cash | $34 | -$5 | $13 | $1 |
| Operating Cash Flow | $132 | $32 | -$159 | $46 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$54 | -$18 | -$12 | -$17 |
| Net Acquisitions | $0 | -$2 | -$92 | $0 |
| Inv. Purchases | -$2 | -$108 | -$67 | -$1,133 |
| Inv. Sales/Matur. | $140 | $866 | $809 | $1,217 |
| Other Inv. Act. | $138 | -$864 | -$809 | -$0 |
| Investing Cash Flow | $84 | -$126 | -$171 | $68 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | -$25 | -$24 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$25 | -$24 |
| Financing Cash Flow | $0 | $0 | -$25 | -$24 |
| Forex Effect | -$0 | -$3 | $0 | $3 |
| Net Chg. in Cash | $208 | -$97 | -$354 | $92 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $154 | $251 | $605 | $513 |
| End Cash | $363 | $154 | $251 | $605 |
| Free Cash Flow | $78 | $14 | -$171 | $29 |